1 University Avenue
Macquarie University
Sydney, NSW 2109
Australia
61 2 9428 6555
https://www.cochlear.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 4.996
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, President & Executive Director | 4,34M | N/D | 1967 |
Mr. Stuart Sayers | Chief Financial Officer | 1,86M | N/D | N/D |
Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 1,96M | N/D | 1965 |
Ms. Karen O'Driscoll | Chief Information Officer | N/D | N/D | N/D |
Ms. Kristina Devon | Vice President of Investor Relations | N/D | N/D | N/D |
Mr. Rob McGrory | Group General Counsel & Company Secretary | N/D | N/D | N/D |
Ms. Jennifer Stevenson | VP of Corporate Communications & Brand | N/D | N/D | N/D |
Mr. Dean Phizacklea | Senior Vice President of Global Strategic Marketing | N/D | N/D | N/D |
Ms. Jennifer Hornery | Senior Vice President of Global People & Culture | N/D | N/D | N/D |
Mr. Greg Bodkin BE (Hons), MComm (UNSW) | Senior Vice President of Global Supply Chain | N/D | N/D | N/D |
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
L'ISS Governance QualityScore di Cochlear Limited al 1 settembre 2024 è 1. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 1; diritti degli azionisti: 1; retribuzione: 1.